Curious about today's AI digest?ai-tldr.dev

Daily Digest

BriefMarket · bullishLow impact
Esc
Lead image from the Investing.com report on WuXi AppTec shares after its removal from the Pentagon military list
Photo: Investing.com

WuXi AppTec Stock Rises 2% After 1260H List Removal

Investing.com2 min read6 sources

Why is WuXi AppTec stock up today?

WuXi AppTec (2359.HK) shares rose about 2% to HK$203 on Tuesday after the Pentagon removed the drugmaker from its 1260H Chinese military list, following a court order.

Key numbers

WuXi AppTec at Hong Kong open+6.1%Tue 10 Nov
Hong Kong price (per Investing.com)HK$201.40+1.7%
Session highHK$209.6gains later pared to ~2%
US share of 2025 revenue72%exposure to US customers
Entities on June 8 list expansion188WuXi among them
Initial BIOSECURE Act list dueDec 18, 2026set by law

What happened

WuXi AppTec (2359.HK) shares rose about 2% to HK$203 on Tuesday after the Pentagon removed the drugmaker from its 1260H Chinese military list, following a court order. The list names companies the Pentagon says have ties to China's military, and it added WuXi to it on June 8. A federal judge paused the listing on August 7, saying the Pentagon's reasoning was likely flawed. The Pentagon removed WuXi on November 9 but said it could relist the company on other grounds.

Why it matters

WuXi AppTec does research and manufacturing work for drug companies, and the United States made up 72% of its 2025 sales. After the listing, customers and suppliers cancelled contracts or moved work to rivals, the judge noted. Removal eases that worry. The court order is not a final ruling, though, and the company could still face other US rules, such as the BIOSECURE Act.

Who this affects

Marketbullish
Low impact
Hong Kong biotech stocks rose, good for holders.
Companybullish
Medium impact
WuXi AppTec sheds the military label, good for shareholders.
Competitorsbearish
Low impact
Rivals may lose customers who had moved work to them.
Industrymixed
Low impact
Drug makers using Chinese suppliers face less immediate disruption.

WuXi AppTec vs WuXi Biologics, BeOne Medicines

WuXi AppTec2359.HK+6.1%HK$203
WuXi Biologics2269.HK+3.6%—
BeOne Medicines6160.HK+7.5%—

As of 2026-11-10

How we got here

  1. Pentagon adds WuXi AppTec to its 1260H list of Chinese military companies.

  2. WuXi AppTec sues the Defense Department over the designation.

  3. Federal judge grants preliminary injunction blocking enforcement of the designation.

  4. Pentagon removes WuXi AppTec, without prejudice to relisting on other grounds.

  5. WuXi AppTec opens up 6.1% in Hong Kong, then pares gains to about 2%.

What to watch

  • Whether the Pentagon relists WuXi AppTec on new or supplementary grounds.TBD
  • White House budget office publishes its first BIOSECURE Act list of companies of concern.2026-12-18

Educational content only. Not investment advice.

More briefsAll briefs →